Sina Noshad

2.9k total citations
57 papers, 1.7k citations indexed

About

Sina Noshad is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Molecular Biology. According to data from OpenAlex, Sina Noshad has authored 57 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Endocrinology, Diabetes and Metabolism, 19 papers in Epidemiology and 17 papers in Molecular Biology. Recurrent topics in Sina Noshad's work include Adipokines, Inflammation, and Metabolic Diseases (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers) and Metabolism, Diabetes, and Cancer (6 papers). Sina Noshad is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers) and Metabolism, Diabetes, and Cancer (6 papers). Sina Noshad collaborates with scholars based in Iran, United States and Taiwan. Sina Noshad's co-authors include Alireza Esteghamati, Manouchehr Nakhjavani, Mostafa Mousavizadeh, Mohsen Afarideh, Elias Khajeh, Omid Khalilzadeh, Hossein Mirmiranpour, Alipasha Meysamie, Alireza Ghajar and Jeffrey I. Mechanick and has published in prestigious journals such as Neurology, Scientific Reports and British Journal Of Nutrition.

In The Last Decade

Sina Noshad

57 papers receiving 1.7k citations

Peers

Sina Noshad
Yoon‐Hee Choi South Korea
Jeffrey King United Arab Emirates
Eric S. H. Lau Hong Kong
George Alberti United Kingdom
Seung‐Won Oh South Korea
Sina Noshad
Citations per year, relative to Sina Noshad Sina Noshad (= 1×) peers Sergio Valdés

Countries citing papers authored by Sina Noshad

Since Specialization
Citations

This map shows the geographic impact of Sina Noshad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sina Noshad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sina Noshad more than expected).

Fields of papers citing papers by Sina Noshad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sina Noshad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sina Noshad. The network helps show where Sina Noshad may publish in the future.

Co-authorship network of co-authors of Sina Noshad

This figure shows the co-authorship network connecting the top 25 collaborators of Sina Noshad. A scholar is included among the top collaborators of Sina Noshad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sina Noshad. Sina Noshad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gbadamosi, Semiu O., et al.. (2025). Association of Index and Changes in Fibrosis-4 Score With Outcomes in Metabolic Dysfunction-Associated Steatohepatitis. Gastro Hep Advances. 4(7). 100666–100666. 3 indexed citations
2.
Reading, Stephanie, et al.. (2022). Lipid Testing Trends Before and After Hospitalization for Myocardial Infarction Among Adults in the United States, 2008–2019. Clinical Epidemiology. Volume 14. 737–748. 5 indexed citations
3.
Abbasi, Mehrshad, Mohamadreza Neishaboury, Jalil Koohpayehzadeh, et al.. (2018). National Prevalence of Self-Reported Coronary Heart Disease and Chronic Stable Angina Pectoris: Factor Analysis of the Underlying Cardiometabolic Risk Factors in the SuRFNCD-2011. Global Heart. 13(2). 73–73. 17 indexed citations
4.
Farazmand, Ali, Alireza Esteghamati, Sina Noshad, et al.. (2017). Association of Human Leukocyte Antigens Class I and II with Graves' Disease in Iranian Population.. PubMed. 14(3). 223–230. 11 indexed citations
5.
Yaseri, Mehdi, Mohsen Afarideh, Mostafa Hosseini, et al.. (2017). Zero and Five End-Digit Preference and Blood Pressure Quality of Care Revisited.. PubMed. 20(10). 633–639. 3 indexed citations
6.
Noshad, Sina, Mona Shahriari, Mohsen Afarideh, et al.. (2017). Inverse Association of Peripheral Orexin-A with Insulin Resistance in Type 2 Diabetes Mellitus: A Randomized Clinical Trial. The Review of Diabetic Studies. 14(2-3). 301–310. 12 indexed citations
7.
Kahe, Farima, Jolanta Marszałek, Mohsen Afarideh, et al.. (2017). Intercellular adhesion molecule-1 in diabetic patients with and without microalbuminuria. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 12(3). 365–368. 27 indexed citations
8.
Esteghamati, Alireza, Koorosh Etemad, Jalil Koohpayehzadeh, et al.. (2016). Awareness, Treatment and Control of Pre-hypertension and Hypertension among Adults in Iran.. PubMed. 19(7). 456–64. 38 indexed citations
9.
Esteghamati, Alireza, et al.. (2016). Serum fibroblast growth factor 21 concentrations in type 2 diabetic retinopathy patients. Annales d Endocrinologie. 77(5). 586–592. 21 indexed citations
10.
Afarideh, Mohsen, et al.. (2016). Raised serum 25-hydroxyvitamin D levels in patients with active diabetic foot ulcers. British Journal Of Nutrition. 115(11). 1938–1946. 32 indexed citations
11.
Afarideh, Mohsen, Zahra Aryan, Alireza Ghajar, et al.. (2016). Complex association of serum alanine aminotransferase with the risk of future cardiovascular disease in type 2 diabetes. Atherosclerosis. 254. 42–51. 21 indexed citations
12.
Farshchi, Amir, et al.. (2016). Biphasic insulin Aspart 30 vs. NPH plus regular human insulin in type 2 diabetes patients; a cost-effectiveness study. BMC Endocrine Disorders. 16(1). 35–35. 8 indexed citations
13.
Esteghamati, Alireza, et al.. (2015). Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes. Archives of cardiovascular diseases. 108(8-9). 412–419. 21 indexed citations
14.
Hoseini, Seyed Mehdi, Ali Kalantari‐Hesari, Mohsen Afarideh, et al.. (2014). Evaluation of plasma MMP-8, MMP-9 and TIMP-1 identifies candidate cardiometabolic risk marker in metabolic syndrome: results from double-blinded nested case–control study. Metabolism. 64(4). 527–538. 28 indexed citations
15.
Farazmand, Ali, et al.. (2014). Polymorphism of killer cell immunoglobulin-like receptors (KIR) and their HLA ligands in Graves’ disease. Molecular Biology Reports. 41(8). 5367–5374. 8 indexed citations
16.
Binesh, Fariba, et al.. (2013). Malignancy Risk Assessment in Patients with Thyroid Nodules Using Classification and Regression Trees. Journal of Thyroid Research. 2013. 1–9. 8 indexed citations
17.
Koohpayehzadeh, Jalil, Koorosh Etemad, Mehrshad Abbasi, et al.. (2013). Gender-specific changes in physical activity pattern in Iran: national surveillance of risk factors of non-communicable diseases (2007–2011). International Journal of Public Health. 59(2). 231–241. 58 indexed citations
19.
Esteghamati, Alireza, Sina Noshad, Omid Khalilzadeh, et al.. (2011). Contribution of Serum Leptin to Metabolic Syndrome in Obese and Nonobese Subjects. Archives of Medical Research. 42(3). 244–251. 34 indexed citations
20.
Esteghamati, Alireza, Sina Noshad, Omid Khalilzadeh, et al.. (2010). Insulin Resistance Is Independently Associated with Liver Aminotransferases in Diabetic Patients Without Ultrasound Signs of Nonalcoholic Fatty Liver Disease. Metabolic Syndrome and Related Disorders. 9(2). 111–117. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026